Close Menu

Verily, Alphabet's life sciences company, is adapting its Project Baseline study to also examine how the immune system reacts to SARS-CoV-2 infections, CNBC reports.

Verily launched Project Baseline in 2017. The project aimed to analyze genetic data, blood samples, imaging, and more from 10,000 volunteers to get a sense of what a healthy person looks like. 

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

A new study finds that three dimensional facial scans may be able to aid in diagnosing rare genetic diseases.

The Lancet and the New England Journal of Medicine have retracted two COVID-19 papers due to concerns about the data used in their analyses.

Lawmakers plan to introduce a bill that aims to prevent the theft of US-funded research, according to the Wall Street Journal.

In Science this week: analysis of ancient Caribbean islanders' genomes suggests at least three waves of migration into the region,  DNA barcoding of microbial spores, and more.